NCT07189637Recruiting
The Combined Effect of the Mediterranean Diet and Intermittent Fasting on Hypertension
Source: ClinicalTrials.gov · Last updated 25 Sept 2026
Brief summary (registry, in English)
Hypertension (HT) is an important risk factor for cardiovascular diseases (CVD) and death. Approximately 16.9 million people in Turkey have HT. Nutritional habits play an important role in the development of HT. DASH (Dietary Approaches to Stop Hypertension) and the Mediterranean diet (MD) have been found to be effective in lowering blood pressure and reducing cardiometabolic risks. The DASH diet stands out with its low sodium, saturated fat, simple sugar and cholesterol content, while it is rich in fiber, potassium, magnesium and anti-inflammatory components. The MD is based on healthy foods such as olive oil, vegetables, fruits, fish and nuts, and contains antioxidants and healthy fatty acids. This study will investigate whether the sodium-restricted MD can offer a model comparable to DASH. In addition, the effects of the intermittent fasting diet (IFD) model alone and in combination with the MD on blood pressure will be examined. It has been observed that IFD reduces blood pressure by reducing energy intake and acting on the autonomic nervous system. The aim of this project is to evaluate the effects of MD, IFD and both of them on hypertension and to present a new and original approach in this field.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- First submitted
- 13 Sept 2025
- Start date
- 13 Dec 2025
- Primary completion date
- 15 Dec 2026
- Lead sponsor
- Nadide Gizem Tarakci Filiz
- Diseases
- High blood pressure
- NCT number
- NCT07189637
What you commit to
- Study type: Interventional
- Planned participants: 48
- From 13 Dec 2025 to the primary completion date, 15 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Type 2 Diabetes Mellitus
- Type 1 Diabetes Mellitus
- Cardiovascular disease
- Liver disease
- Kidney disease
- Gastrointestinal disease
- Respiratory disease
- Psychiatric disorders
- Severe food allergies
- History of major surgery within the last 6 months
Other
- Participants will be excluded if they have any of the following:
- Women who are pregnant or breastfeeding
- Current smokers or individuals consuming alcohol regularly
Who the study is looking for
- Newly diagnosed hypertension patients
- Individuals with blood pressure \>140/90 mmHg
- Individuals with a body mass index (BMI) in the range of 18.5-25 kg/m²
- Individuals aged 40-65 years
Age in the registry: 40 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medipol Mega University Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.